HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$4.27
Day range
$4.17 - $4.30
Year range
$3.11 - $11.20
Market cap
127.03M USD
Avg Volume
117.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.91M | 169.36% |
Net income | -2.90M | 68.93% |
Net profit margin | — | — |
Earnings per share | -0.07 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.27M | 102,753.86% |
Total assets | 1.32M | -72.26% |
Total liabilities | 680.97K | -49.01% |
Total equity | 643.04K | — |
Shares outstanding | 29.76M | — |
Price to book | 213.50 | — |
Return on assets | -614.00% | — |
Return on capital | -1,142.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.90M | 68.93% |
Cash from operations | -605.81K | 44.28% |
Cash from investing | — | — |
Cash from financing | 1.04M | -4.48% |
Net change in cash | 431.49K | 35,439.31% |
Free cash flow | 476.67K | 216.54% |
About
Founded
2021
Headquarters
Website
Employees
5
